Contract research organization ALMEDIS
E-mail:
info@almedis.ru
Tel: +7 495 937 43 18
Fax: +7 495 937 43 19
Address: 5, Ulitsa Malaya Pirogovskaya, office 22, 119435 Moscow, Russia

RUS ENG
About Us
Our Services
Quality
Contact Us
News
Links
Career

ALMEDIS is an independent contract research organization (CRO) with operations all over Russia

ALMEDIS provides comprehensive range of services in international and local clinical trials, observational studies, data management, biostatistics, medical writing and training programs.

Our CRO is committed to meeting the needs and expectations of our clients by providing professional and superior quality service, with integrity, reliability and strong client focus.

ALMEDIS is a member of the Association of Clinical Trial Organizations (ACTO).

    ALMEDIS is an Effective Resource for:
  • International pharmaceutical companies
  • International contract research organizations (CROs)
  • Pharmaceutical and biotech companies launching their clinical research activities in Russia
  • Scientific research organizations

Since 2007 ALMEDIS team has successfully managed more than 100 projects, including international and local Phase II - IV clinical trials and observational studies.

This year ALMEDIS marks the decade of successful collaboration with a leading international Life Sciences technology provider Ennov

          Latest News:
  • The next interim statistical was completed for Phase II study on the efficacy and safety of oral combination therapy with patients with chronic hepatitis C.
  • On November 13-14, 2018 ALMEDIS took part in the international forum “Clinical research in Russia” by Adam Smith. ALMEDIS presented its practical experience in supporting of investigator initiated trials in Russia.
  • The last patient last visit was conducted in Phase II study on the efficacy and safety of oral combination therapy with patients with chronic hepatitis C.
  • A project for Russian translation, adaptation and validation of a special questionnaire for patients with oncohematological disease, coordinated by ALMEDIS, was launched.

 




ALMEDIS is solely responsible for this site content. This information is intended for use by our customers and clinical research specialists.
© 2006-2018 ALMEDIS All rights reserved 

Privacy Policy